Veerhealth Care Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved these results at their meeting held on February 14, 2026, pursuant to Regulation 30 and 33 of the SEBI Listing Regulations.

Financial Performance Overview

The company's financial performance for the reporting period shows the following key metrics:

Expense Breakdown

The company's major expense categories for Q3FY26 included:

• Purchase of stock-in-trade: ₹320.50 lakhs
• Changes in inventories: ₹187.42 lakhs
• Other expenses: ₹110.88 lakhs
• Employee benefits expense: ₹45.89 lakhs
• Depreciation and amortisation: ₹35.01 lakhs
• Finance costs: ₹9.56 lakhs

Key Financial Metrics

Corporate Governance and Compliance

The financial results were reviewed by the Audit Committee and approved by the Board of Directors. The Limited Review under Regulation 33 of the SEBI Listing Regulations was conducted by statutory auditors Jayesh R. Shah & Co., Chartered Accountants. The limited review report contained no observations that would impact the results.

The company operates in a single segment of 'Healthcare Pharma Products', making segment-wise reporting not applicable. The standalone financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013.

Board Meeting Details

The Board meeting commenced at 4:00 PM and concluded at 4:30 PM on February 14, 2026. Managing Director Bhavin S. Shah (DIN: 03129574) signed the results announcement. The financial results are available on the company's website at https://veerhealthcare.net/ and on BSE's website.

Veerhealth Care Ltd has announced the appointment of Ms. Ashita Chittora as the company's new Company Secretary and Compliance Officer, following a board meeting held on February 02, 2026. The appointment takes effect immediately from the same date and was made in compliance with regulatory requirements under the Companies Act, 2013 and SEBI regulations.

Board Meeting Details

The board meeting that approved this appointment commenced at 02.00 P.M. and concluded at 02.30 P.M. on February 02, 2026. The decision was made in accordance with the provisions of Section 203 of the Companies Act, 2013, and Rule made thereunder, as well as Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointee Profile and Qualifications

Ms. Ashita Chittora brings substantial expertise to her new role as Company Secretary and Compliance Officer. She is an Associate Member of the Institute of Company Secretaries of India with membership number A50327, possessing requisite qualifications and skills in secretarial compliances.

Ms. Chittora has undertaken various assignments and possesses good experience in Corporate Law and Listing Regulations, making her well-suited for the compliance responsibilities at Veerhealth Care Ltd.

Regulatory Compliance

The appointment has been made in full compliance with regulatory requirements under Regulation 6(1) & 30(4) read with Para A of Part A of Schedule II of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The company has provided all details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Information

Veerhealth Care Ltd operates from its registered office at 629-A Gazdar House, 1st Floor, Near Kalbadevi Post Office, J.S.S. Marg, Mumbai - 400 002. The company also has manufacturing works located at Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. 8, Vapi - 396191, Gujarat. The announcement was signed by Managing Director Bhavin Satish Shah (DIN: 03129574), who requested BSE Limited to update their records accordingly.